Alzheimer's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a possible or probable behavioural form of frontotemporal dementia (a type of dementia that mainly affects behaviour and personality), based on a specific set of medical guidelines from 2011
- People who have been diagnosed with Alzheimer's disease, confirmed using brain or biological markers, based on a specific set of medical guidelines from 2018
- People whose score on a standard memory and thinking test (called the MMSE) is 20 or above, indicating mild rather than severe cognitive difficulties
- People aged between 50 and 80 years old
- People who, in the opinion of the trial investigator, can read and write in French well enough to complete the study tasks
Who may not be able to join:
- People who have moderate to severe difficulties with language, specifically those who score 32 or below on a standard picture-naming test (called the DO 40)
- People who, in the opinion of the trial investigator, are unable to use or complete tasks on a computer
- People who have other neurological conditions, such as epilepsy, Lewy body disease, or vascular dementia (a type of dementia caused by reduced blood flow to the brain)
- People who have certain psychiatric conditions, including bipolar disorder, schizophrenia, or a current major depressive episode
- People who have vision problems that have not been corrected with glasses or other means
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 (0) 1 40 05 49 54
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Metacognitive efficiency during facial emotion recognition (Mratio)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.